Format

Send to

Choose Destination
See comment in PubMed Commons below
Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):665-75. doi: 10.1016/j.diii.2014.04.002. Epub 2014 Apr 26.

Percutaneous hepatic ablation: what needs to be known in 2014.

Author information

1
Department of Radiology, Jean-Verdier Hospital, avenue du 14-Juillet, 93140 Bondy, France. Electronic address: olivier.seror@jvr.aphp.fr.

Abstract

Percutaneous treatments for liver tumors were initially reserved for patients deemed to be inoperable and whose tumors were small in both size and number. As a result of the widening range of both techniques and technologies these treatments have gradually become incorporated into increasingly complex treatment strategies for increasingly broad patient groups. The place reserved for these techniques, which are still dominated by monopolar radiofrequency ablation, which is now facing strong competition from second-generation microwaves, is governed by each center's knowledge and skills in the techniques. This review describes the possible indications for percutaneous ablation depending on clinical findings and the technical and technological choices made.

KEYWORDS:

Electroporation; Liver; Malignant tumor; Monopolar radiofrequency ablation; Multipolar radiofrequency ablation

PMID:
24776811
DOI:
10.1016/j.diii.2014.04.002
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center